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Abstract
Background: Geranium sibiricum L. has been used as a medicinal plant to treat diarrhea, bacterial infection, and
cancer in Bulgaria, Peru, and Korea. However, its hair growth-promoting effect was not investigated so far. This
study examined the effects of Geranium sibiricum L. extract (GSE) on hair growth, using in vitro and in vivo models.
Methods: Antioxidant, proliferation and migration assay of GSE was performed with human dermal papilla cells
(hDPCs). Hair-growth promoting effect was measured in animal model. Relative expression of interleukin-1, vascular
endothelial growth factor, hepatocyte growth factor, and transforming growth factor beta 1 was determined by real
time RT-PCR. Expression of Ki-67 and stem cell factor were analyzed by immunohistochemistry.
Results: GSE treatment proliferated and migrated human dermal papilla cells (hDPCs) more than treatment of
10 μM minoxidil. GSE significantly stimulated the expression of Ki-67 protein and the mRNA levels of hepatocyte
growth factor and vascular endothelial growth factor in hDPCs. Topical application of 1,000 ppm GSE for 3 weeks
promoted more significant hair growth on shaved C57BL/6 mice than did 5% minoxidil. The histological morphology
of hair follicles demonstrated an active anagen phase with the induction of stem cell factor. GSE treatment significantly
reduced the number of mast cells and the expression of transforming growth factor beta 1 in mouse skin tissues.
Conclusions: These results demonstrated that GSE promotes hair growth in vitro and in vivo by regulating growth
factors and the cellular response.
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Background
Hair loss is defined as a state in which hair does not
exist at a typical area or less hair regrowth is observed
in the area [1]. In modern society, hair loss occurs via
genetic reasons as well as external factors such as
environmental pollution, work stress, and alteration of
hormone secretion [1]. Minoxidil and finasteride are
the only chemicals approved by the US Food and Drug
Administration to treat hair loss [2–4]. However, both
these chemicals have serious adverse effects such as
weight gain, edema, angina pectoris, and hypogonadism
in men and can lead to the birth of deformed baby if
used by pregnant women. In efforts to find natural sub-
stances that are less toxic than minoxidil and finaste-
ride, previous studies have screened about 1,000 plant
extracts for hair growth or hair loss-preventing effects
[5, 6]. Among the natural extracts, Allium cepa extract
and Ziziphus jujuba extract were found to promote hair
growth [5, 6], with the antioxidant capacity of each ex-
tract being concluded as the contributing factor.
All living organisms are constantly challenged by a
diversity of exogenous- and endogenous stressors,
which induce biological responses to protect or adapt
to stressors. The systemic biological response of the
organism to stressor induces stress response through
activation of hypothalamic-pituitary-adrenal axis (HPA)
by proinflammatory cytokines to increase circulating
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glucocorticoids and catecholamines [7]. The growing
body of evidence now supports that a wide range of
neuropeptides, neurotransmitters, and neurohormones
modulating systemic stress responses can indeed alter
hair growth, indicating that hair follicles represent an
important target for stressors [8].
Plant phenolics and flavonoid are recently of interest,
since these compounds possess antioxidation, anti-
inflammatory, anti-microbial, and anti-carcinogenic
properties [9]. Geranium sibiricum L., which belongs
to the Geraniaceae family of plants, grows in China,
Japan, Korea, and some European countries. While it
is used as a food ingredient in Russia and Turkey, it
has been used as a medicinal plant to treat diarrhea,
bacterial infection, and cancer in Bulgaria, Peru, and
Korea [10]. The extract and phenolic compounds from
G. sibiricum showed high antioxidant capacity in 1,1-
diphenyl-2-picrylhydrazyl (DPPH) radical scavenging,
superoxide radical scavenging, nitric oxide scavenging,
β-carotene-linoleic acid bleaching, and reducing power
[11]. As several pharmacological studies of G. sibiricum
have shown anti-inflammatory, anti-bacterial, anti-
diarrheal effect and anti-gastric ulcer action [12–15], it
is widely used in cosmetic industry nowadays. Shim et al.
[16] has reported that ethanol extract of Geranium sibiri-
cum L. decreased expression of interleukin (IL)-1β, COX-
2 and inducible nitric oxide synthase (iNOS) in PMACI
stimulated HMC-1 cells. IL-1β and COX-2 are known as
potent inhibitors of hair growth in vitro and in vivo. Inui
et al. [17] has also found that dihydrotestosterone (DHT),
contributing to androgenic alopecia, increases iNOS from
occipital dermal papilla cells and suggested that iNOS and
NO are downstream effectors of androgen receptors.
However, the effects of G. sibiricum extract (GSE) on hair
growth have not been studied so far. Therefore, the study
aimed to investigate whether the topical treatment of GSE
could promote hair growth in vitro and in vivo models by
regulating the expression of growth factors and inflamma-
tory cytokines.
Methods
Preparation of GSE and HPLC analysis
GSE was purchased from a Korea Plant Extract Bank at
Korea Research Institute of Bioscience & Biotechnology
(KRIBB, Daejeon, Korea). G. sibiricum L. used in this
study were collected from Mountain Gamak in Paju-si,
Korea. Botanical samples were authenticated by Professor
Shin-Ho Kang from Department of Natural Medicine
Resources in Semyung University. The air-dried plant
materials were ground into fine powder and extracted with
100% methanol. After filtration of total extract, the extract
was evaporated to dryness in vacuum and weighed. The
recovery rate was 6.7%.
GSE was dissolved in dimethylsulfoxide (DMSO).
Water, acetonitrile (ACN), and methanol (MeOH) used in
this research were of HPLC grade, and all other reagents
were of analytical grade. Corilagin and gallic acid were
provided by Professor Sam Sik Kang, Seoul National
University, Korea. They were used as standard chem-
ical for high pressure liquid chromatography (HPLC)
analysis. HPLC chromatograms were recorded with a
Waters Breeze system (Massachusetts, USA) equipped
with a Waters 1525 binary HPLC pump and 2489 sys-
tem UV/VIS detector.
HPLC separation of corilagin and gallic acid for quali-
tative and quantitative analysis was performed using a
reverse phase system. Discovery® C18 (4.6 × 250 mm,
5 μm) column was used with a mobile phase consisting
of a gradient system of water containing 0.2% acetic acid
and ACN (90:10 to 60:40 for 30 min). UV detection was
conducted at 270 nm. The injection volume was 10 μl
and the flow rate was 1 mL/min. All injections were
performed in triplicate. Corilagin and gallic acid were
weighed and dissolved in MeOH to obtain a stock stand-
ard solution (1.0 mg/mL). Solutions of aqueous corilagin
and gallic acid were prepared at concentrations of
0.0001, 0.001, 0.01, 0.1, and 1 mg/mL for the construction
of a calibration curve. The contents of the analysis
were determined from the corresponding calibration
curves. The calibration functions of the compound
were calculated using the peak area (Y), concentration
(X, μg/10 μl), and mean values (n = 3) ± standard devi-
ation (SD).
Antioxidative activity of GSE
The analysis of total polyphenol content was determined
using Folin-Denis method. Point five milliliter of GSE
prepared 50% methanol at concentration of 0.2 mg/mL
was mixed with 0.5 mL of Folin-Denis reagent (Fluka,
Buchs, Switzerland) and was added to 0.5 mL of 10%
sodium carbonate solution after 3 min at room
temperature. The mixture was kept at room temperature
for 1 h and then the absorbance was measured at
760 nm using 7315 UV spectrophotometer (JENWAY,
Staffordshire, United Kingdom). Total polyphenol con-
tent was expressed as mg of tannic acid (Yakuri Pure
Chemicals Co., Ltd., Kyoto, Japan) equivalent (TAE).
To determine the total flavonoid content, 0.5 mL of
the 0.2 mg/mL dissolved in methanolic GSE was mixed
with 5 mL of diethylene glycol (Duksan Pure Chemicals,
Ansan, Korea). After 5 min at room temperature, the
mixture was added to 0.5 mL of 1 N NaOH (Duksan
Pure Chemicals, Ansan, Korea) and allowed to stand for
1 h in 37 °C water bath. The absorbance was measured
at 420 nm using 7315 UV spectrophotometer (JENWAY,
Staffordshire, United Kingdom). Total flavonoid content
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was expressed as mg of naringin (Tokyo Kasei Kogyo
Co., Ltd., Tokyo, Japan) equivalent (NE).
The method was conducted as described by Blois [18]
with some modifications to determine DPPH scavenging
activity of GSE. 0.5 mL of diluted to 0.2 mg/ mL GSE
was mixed with 3 mL of 0.2 mM methanolic DPPH
solution. 0.5 ml of 100% methanol was used as a carrier
control. After 30 min in the dark at room temperature,
the absorbance of the mixture was measured at 517 nm
by a 7315 UV spectrophotometer (JENWAY, Staffordshire,
United Kingdom). The electron donating ability (EDA)
was calculated by the following equation.
EDA %ð Þ ¼ ABScontrol− ABSsample
ABScontrol
 100
Proliferation and migration assay of human dermal
papilla cells (hDPCs)
Cell proliferation was determined by Cell Counting Kit-
8 (CCK-8) (Sigma, St. Louis, MO, USA). hDPCs were
seeded at a density of 5 × 103 cells/well of a 96-well
microplate. After incubation for 24 h, the cells were
cultured with 100 μL of serum-free Dulbecco’s modified
Eagle’s medium (DMEM, Sigma) for 24 h and then
treated with 9.8, 19.5, 39.1, 78.1, 156.3 μg/mL of GSE
in DMEM. Serum-free DMEM medium and triton X-
100 (Sigma, St. Louis, MO, USA) were used as negative
control (NC) and blank, respectively. Boyera et al. [19]
has found that micromolar concentrations of minoxidil
stimulated proliferation in both human keratinocytes of
epidermal and hair follicle origin cell types and in all
culture conditions, whereas millimolar concentrations
inhibited cell growth. Similarly, treatment concentra-
tion of minoxidil was examined for hair growth effect
with less toxicity in our preliminary study. Thus, 10 μM
minoxidil was used as positive control (PC) in vitro
assay. After treatment for 24 h, 10 μL of CCK-8 solu-
tion was added to each well, the cells were then incu-
bated at 37 °C for 3 h. The absorbance was measured at
450 nm (test wavelength) and 650 nm (reference wave-
length) by microplate spectrophotometer (Epoch Multi-
Volume Spectrophotometer System, BioTek, VT, USA).
The measured absorbance was used to determine cell
proliferation by the following equation.






ABScontrol‐ABSblankð Þ450nm‐ ABScontrol‐ABSblankð Þ650nm
 100
Migration assay was conducted as describe by previous
study [20]. hDPCs were plated on 8-well chamber slide
(Nalge Nunc International, Naperville, Illinois, USA) and
grown to 90% confluence in 10% FBS DMEM medium.
The cells were then scratched in straight line with
200 μL pipette tip and the cell debris was removed by
washing the cells with sterile PBS. hDPCs were treated
with 9.8, 19.5, 39.1, 78.3 μg/mL of GSE. Serum-free
DMEM medium and 10 μM minoxidil were used as NC
and PC, respectively. After incubation for 24 h, hDPCs
were fixed with 4% paraformaldehyde, washed two times
with phosphate buffered saline (PBS). The cells were
stained with hematoxylin (Sigma, St. Louis, MO, USA)
and images were taken using a Leica 500 optical
microscope (Leica, Wetzlar, Germany) at a magnifica-
tion of 40 ×.
Animal care and in vivo experiment for hair growth
Fifteen male 4-week-old C57BL/6 mice were pur-
chased from Central Lab, Animal Inc. (Seoul, Korea).
The mice were acclimated to their surroundings for
2 weeks to lead to the early onset of the telogen phase
in mice hair cycles. Mice were randomly assigned to
the experimental groups with 5 mice per group and
were singly housed in cages to minimize the loss of
the topically applied extracts by contact with other
mice. All animals were bred in a laminar airflow room
with 12 h of artificial light and darkness for 1 week.
Animal facility was maintained at 22 ± 1 °C room
temperature and a relative humidity of 55 ± 10%. All
experimental procedures were approved by the Animal
Care Committee of the Chung-Ang University (ap-
proval no: 13–0058).
Experimental groups contained NC, PC, and GSE
group. Mice were randomly separated into three groups
with five mice per group. In order to synchronize the
stage of hair growth, back skin of all experimental
animals were artificially shaved. Topical treatments on
the shaved back skin were applied daily with 1% di-
methyl sulfoxide (NC group), 5% minoxidil (dissolved
into 1% DMSO) (PC group), or GSE dissolved in 1%
DMSO with the final concentration of 1,000 ppm. Hair
growth of each mouse was measured and photographed
every week for 3 weeks after shave.
Histopathology of hair growth
Dorsal skin tissues from each mouse were excised and
fixed in 4% neutral formalin for 24 h. They were embed-
ded in paraffin after routine tissue processing. For the
histopathogic evaluation of hair follicles, 4 μm tissue
section was stained with standard hematoxylin and eosin
(H&E) protocol. For the counting of mast cells, toluidine
blue stain (Sigma, St. Louis, MO, USA) was performed
on skin tissues by manufacturer’s protocol. The morph-
ology of hair follicles, the number of mast cells, and
expression of stem cell factor (SCF) were evaluated by
veterinary pathologists.
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Immunohistochemistry of Ki-67 and stem cell factor
To confirm the effect of GSE on hDPCs proliferation,
the immunohistochemistry for Ki-67 was performed
with some modification described in previous study
[21]. hDPCs were seeded at a density of 2 × 103 cells/
well of an 8-well chamber slide and incubated until
grow to 80-90% confluence in 10% FBS DMEM
medium. After culture with serum-free DMEM
medium for 24 h, the cells were added to each treat-
ment and incubated for 24 h; serum-free DMEM (NC),
10 μM minoxidil (PC), 19.5 μg/mL of GSE. The cells
were fixed for 20 min with 4% paraformaldehyde,
washed three times with PBS. Endogenous alkaline
phosphatase was quenched with levamisole and 10%
normal goat serum was used for blocking non-specific
reaction. Monoclonal mouse anti-human Ki-67 antibody
(DAKO, Glostrup, Denmark) at 1:100 was incubated for
1 h at room temperature. Polyclonal goat anti-mouse im-
munoglobulins/alkaline phosphatase (DAKO, Glosturp,
Denmark) was applied for 1 h. Positive signals were visual-
ized with freshly prepared fast red (Vector Laboratories
Inc., Burlingame, California, USA). Images were taken
using a Leica DM 500 optical microscope (Leica, Wetzlar,
Germany) at a magnification of 200 ×.
In order to examine the expression of the stem cell
factor in skin tissues, immunohistochemistry was per-
formed by standard ABC protocol. Mouse anti-stem cell
factor antibody (Santa cruz, Dallas, TX, USA) at 1:100
dilutions was incubated. Secondary antibody used with
polyclonal goat anti-mouse immunoglobulins/horse rad-
ish peroxidase (DAKO, Glosturp, Denmark). For the
substrate of horse radish peroxidase, 3,3’-diaminobenzi-
dine (DAB; Roche Diagnostics GmbH, Mannheim,
Germany) was used to visualize the positive signal on
tissues. Each well was mounted with coverslip using
aqueous mounting media (Vector laboratories).
mRNA relative expression of cytokines
In vitro model, hDPCs were plated on 6-well plate
(3 × 104) and incubated until grow to 80-90% conflu-
ence in 10% FBS DMEM medium. After culture with
serum-free DMEM medium for 24 h, The cells were
added to each treatment and incubated for 24 h;
serum-free DMEM (NC), 10 μM minoxidil (PC),
19.5 μg/mL of GSE. Total RNA was extracted using
RNeasy Mini kit (Qiagen, Dusseldorf, Germany) ac-
cording to manufacturer’s instruction. In vivo model,
mouse skins of each group were collected after 3 weeks
of depilation. Total RNA of skin tissue was extracted
using RNeasy Mini kit (Qiagen) following the manu-
facturer’s instruction.
For analyzing the expression of hepatocyte growth fac-
tor (HGF), vascular endothelial growth factor (VEGF),
and transforming growth factor-beta 1 (TGF-β1) of
hDPC or mouse skin, 1 μg of total RNA was treated with
DNase I (Invitrogen). cDNA of mRNA was synthesized
using cDNA synthesis kit (Thermo Fisher Scientific Inc.,
Waltham, MA, USA). Quantitative real-time polymerase
chain reaction (qPCR) was conducted with Piko-real 96
real-time PCR system (Thermo Fisher Scientific Inc.,
Waltham, MA, USA) and performed for 45 cycles at 95 °C
for 15 s, 60 °C for 30 s, 72 °C for 30 s. cDNA was ampli-
fied using Maxima SYBR Green/ROX qPCR Mater Mix
2X (Thermo Fisher Scientific Inc., Waltham, MA, USA).
Primers were used as follows: glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), 5′-GGA AGG TGA AGG TCG
GAG TC-3′ (forward); GAPDH, 5′-CTC AGC CTT GAC
GGT GCC ATG-3′ (reverse); VEGF, 5′-CTT TAG AGA
TCA GCC CAA CC-3′ (forward); VEGF, 5′-CTA CCC
AGA GGG AAG AAA TAA C-3′ (reverse); HGF, 5′-AGA
AAT GCA GCC AGC ATC AT-3′ (forward); HGF 5′-
CAC ATG GTC CTG ATC CAA TC-3′ (reverse), TGF-
β1; 5′-GCC CTG GAC ACC AAC TAT TG-3′ (forward);
TGF-β1; 5′-GTC CAG GCT CCA AAT GTA GG-3′
(reverse).
Statistical analysis
Data are presented as mean ± standard error (SE). One-
way analysis of variance (ANOVA) and Duncan’s mul-
tiple range test was performed using SPSS program for
windows, version 21.0 (SPSS Inc., Chicago, USA). Statis-
tical significance was defined as p < 0.05.
Results
Active components of GSE
Contents of GSE were analyzed by HPLC (Fig. 1). The
corilagin and gallic acid contents of GSE were quanti-
fied using the linear regression equation. The linear
regression data from the extracts had a good linear
relationship and the resulting equation was valid over
the relevant concentration range. The linear calibration
equations were Y = 917496X + 24289 and Y = 2000000X +
91670, where Y is peak area and X is concentration of cor-
ilagin and gallic acid. The correlation coefficients (r2) of
corilagin and gallic acid were 0.9998 and 0.9997, respect-
ively. The contents of corilagin and gallic acid were deter-
mined as 47.33 ± 1.99 and 3.31 ± 0.33 mg/g of GSE,
respectively (Fig. 1).
Antioxidative activity
In order to compare the antioxidant capacity of GSE, its
total polyphenol and flavonoid contents and EDA were
measured. Total polyphenol, flavonoid and EDA of GSE
were 305.9 mg TAE/g extract, 104 mg NE/g extract and
76.6%, respectively.
Boisvert et al. BMC Complementary and Alternative Medicine  (2017) 17:109 Page 4 of 9
Proliferation and migration of hDPCs
Hair comprises at least fifteen distinct types of cells
where the dermal papilla cell (DPC) is a primary cell
type that regulates hair growth. Thus, determining the
proliferation and migratory effects of GSE on hDPCs is
necessary. The proliferative and migratory effects of GSE
(9.8-156.3 ppm) were measured in hDPCs (Fig. 2a). The
treatment of 19.5 ppm of GSE showed the highest prolif-
eration rate of hDPCs. The proliferation rate of hDPCs
was even higher in 19.5 ppm of GSE than PC by 132.7%
vs. 120.5%. The concentration of 19.5-39.1 ppm GSE
was significantly higher in proliferation rate than NC
(p < 0.05). It was observed that GSE exhibited toxicity
(cell viability less than 85%) above the concentration of
156.3 ppm.
On the other hand, the migration rate of the PC group
was 59%, whereas that of 19.5 ppm GSE-treated group
was 402%, indicating 19.5 ppm GSE-treated group had
the highest migration rate among all the treatment
groups (p < 0.05) (Fig. 2b).
Immunohistochemistry localized the expression of
Ki-67 protein on hDPCs treated with GSE (Fig. 3a).
Positive signal of Ki-67 was observed only in nucleus of
hDPCs. Based on the histomorphologic analysis, Ki-67
protein expression was significantly elevated in the
GSE-treated group (average 13.4 cells) compared with
the NC and PC groups (2.7 and 5.3 cells, respectively)
(Fig. 3b).
mRNA Expression of cytokines in hDPCs
The relative expression levels of VEGF, HGF, and TGF-
β1 in GSE-treated hDPCs were measured by real-time
RT-PCR (Fig. 3c). Compared with NC group, GSE sig-
nificantly upregulated mRNA expression of HGF and
VEGF in hDPCs by 5.85-fold and 3.75-fold, respectively
(p < 0.05). Although TGF-β1 mRNA expression of GSE
was not significantly different with NC group, PC group
significantly increased mRNA expression of TGF-β1
higher than GSE and NC group (p < 0.05).
Histopathology and cytokine expression of depilated
mice
The morphology of the hair follicles, number of mast
cells, and expression of SCF were evaluated by veterinary
pathologists (Fig. 4b). From the histological analysis, it
was observed that the depth of the hair follicle was dee-
per, and the length of the hair follicular shaft was longer
in the GSE group than those in the NC and PC groups
(Fig. 4b). The number of mast cells was significantly
lower in the GSE group (1.75 mast cells) than in the NC
(6.0 mast cells) and PC (7.5 mast cells) groups (Fig. 4b, c).
Mast cells were located in dermal connective tissue. SCF
Fig. 1 HPLC chromatograms of corilagin (a), gallic acid (b), and GSE (c)
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was most strongly expressed at the cytoplasm of skin
epidermis and dermal papillary cells of hair follicles in
GSE-treated group compared to the NC and PC groups
(Fig. 4b). The induction of SCF in the in vivo model
suggested that hDPCs underwent the regeneration
process of hair follicles.
The mRNA expression of cytokines in mouse skins
was measured by qPCR. The expression of HGF, VEGF,
and TGF-β1 was normalized with GAPDH housekeep-
ing gene and presented as fold change. The real-time
RT-PCR results showed that 1,000 ppm GSE treatment
significantly downregulated VEGF, HGF, and TGF-β1
mRNA expression in the mouse skin (Fig. 4d).
Discussion
Several plants have been widely used for treating or
preventing diseases various countries. For instance,
GSE has been used in folk remedies to treat diarrhea,
bacterial infection, and anti-gastric ulcer agent [2]. Re-
cently, scientific studies have shown that GSE holds
pharmacological activity including anti-inflammatory,
anti-bacterial function, anti-diarrhea effect and anti-
gastric ulcer action as well as high ability of DPPH
radical scavenging [11, 12, 14, 15]. However, the ef-
fects of extracts from this plant on hair growth have
not been studied so far. Therefore, we investigated
whether the topical treatment of GSE could promote
hair growth, using in vitro and in vivo models.
This study confirmed the corilagin and gallic acid as
active components of GSE in HPLC chromatogram as
both were identified from G. sibiricum [13]. Other
study also reported the maximum content of gallic acid
in G. sibiricum collected in Liaoning Province, China
[22]. The antioxidant activity of corilagin and gallic acid
was shown by scavenging various radicals effectively
[23, 24]. Anti-inflammatory activity and anti-cancer
effect of corilagin and gallic acid were also addressed in
several studies [25–28]. Furthermore, gallic acid could
prevent allergic reaction by blocking histamine release
and pro-inflammatory cytokine expression in mast cell
[26]. Therefore, it seemed that the action of two major
components of GSE contributed the promoting of hair
growth by reducing inflammation in vitro and in vivo
model.
The total polyphenol and flavonoid contents of GSE in
this study were 305.9 mg TAE/g extract and 104 mg
Fig. 2 Effect of GSE on the proliferation and migration of human
dermal papilla cells (hDPCs) (a) Proliferation of hDPCs was analyzed
by the Cell Counting Kit-8 assay, and values are shown as the mean
with SEM. b Migration effect of GSE was measured by the scratch
migration assay, and the alteration of the scratch line width was
converted into a percentage. NC: negative control of hDPCs treated
with Dulbecco’s modified Eagle’s medium; PC: positive control of
hDPCs treated with 10 μM minoxidil
Fig. 3 Changes in the levels of Ki67 protein, hepatocyte growth factor
(HGF), vascular endothelial growth factor (VEGF), and transforming
growth factor beta 1 (TGF-β1) in human dermal papilla cells (hDPCs)
induced by GSE. a Immunohistochemistry of Ki67. b Numbers of Ki67-
positive cells. c Relative expression levels of HGF, VEGF, and TGF-β1
in GSE-treated hDPCs. The fold changes were normalized to the
expression of glyceraldehyde 3-phosphate dehydrogenase; the
values are expressed as the mean ± SEM. Values sharing the same
superscript letters differ significantly at p < 0.05 by Duncan’s
multiple range test. NC: negative control of hDPCs treated with
Dulbecco’s modified Eagle’s medium; PC: positive control of hDPCs
treated with 10 μM minoxidil; GSE: hDPCs treated with 19.5 ppm GSE
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NE/g extract, respectively. Their values were signifi-
cantly higher than those of Lespedeza cuneata G. Don
(228.9 mg TAE/g extract, 90.2 mg NE/g extract) which
was selected by screening the highest antioxidant extract
from many plant extracts [29]. Moreover, the electron-
donating ability of GSE (76.6%) was not only higher than
the synthetic antioxidants butylated hydroxyanisole
(69.2%) and butylated hydroxytoluene (45.6%) but also
comparable to α-tocopherol (75.1%) and Lespedeza
cuneata G. Don (75.7%) [29, 30]. Naito et al. [31] has re-
ported that lipid peroxides can induce apoptosis of hair
follicle cells and lead to the early onset of catagen phase
in murine since it can produce reactive oxygen species
(ROS) causing apoptosis of hair matrix and epithelial
cells by stimulating the expression of p53. Plant extracts
with high DPPH radical scavenging activity may prevent
hair loss presumably by protecting hair follicle cell from
hydroperoxides.
Cell proliferation and migration are the essential fac-
tors for hair growth [32–34]. 19.5 ppm of GSE showed
cell proliferation and migration of hDPCs significantly
higher than those of NC and PC (Fig. 2). Since GSE in-
duced the proliferation and migration of cultured hDPCs
possibly, GSE could enhance hair growth positively.
However, GSE more than 156.3 ppm caused toxic effect
on hDPCs. The induction of Ki-67 in vitro model
suggested that GSE treatment activates cell proliferation
of hDPCs by maintaining and stimulating the active
phases of cell growth, since the Ki67 marker is expressed
only in the active phases of cell growth, such as the G1,
S, and G2 phases and mitosis [35].
Some cytokines are essential to development,
growth and cycling of hair follicles. The results
revealed that HGF and VEGF mRNA expression level
of hDPCs following treatment with GSE was signifi-
cantly upregulated compared with NC or PC (p <
0.05). Although GSE treatment did not reduce TGF-
β1 mRNA expression significantly compared with the
NC group, the PC group showed significantly higher
mRNA expression of TGF-β1 than the GSE group
(1.21 vs. 0.87). Since HGF and VEGF are known
growth modulators of the follicular papilla in the
anagen stage [34], it stands to reason that the induc-
tion of these growth factors by GSE treatment would
promote the anagen stage or active hair growth. The
downregulation of TGF-β1 may contribute partially
to the prevention of hair loss, because this is involved
in the catagen stage of hair development or the apop-
tosis of hair follicle cells [33]. Considering these find-
ings in the in vitro model, GSE treatment may
promote the anagen stage of hair growth by modulat-
ing growth regulators.
Fig. 4 Hair growth-stimulating effect of GSE in an in vivo model. a Observation of C57BL/6 mice hair growth for 3 weeks. b Histological analysis
of hair follicles, mast cells, and stem cell factor expression on the back skin of C57BL/6 mice. c The numbers of mast cells were counted by
toluidine blue staining. d Expression of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and transforming growth
factor beta 1 (TGF-β1) in the back skin of C57BL/6 mice. The fold changes were normalized to the expression of glyceraldehyde 3-phosphate
dehydrogenase; the values are expressed as the mean ± SEM. Values sharing the same superscript letters differ significantly at p < 0.05 by Duncan’s
multiple range test. NC: negative control of C57BL/6 mice skin treated with dimethyl sulfoxide; PC: positive control of C57BL/6 mice skin treated with
5% minoxidil; GSE: C57BL/6 mice skin treated with 1,000 ppm GSE
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We had also conducted in vivo study to determine hair
growth effect of GSE in induced telogenic C57BL/6
mice. From the histological analysis, the depth and de-
velopment of dermal papillar and the long hair shaft of
hair follicles in the GSE group indicated active hair
growth rather than in the NC and PC groups. As mast
cells play a key role in stress reaction and inflammation,
the degranulation of inflammatory mediators by mast
cells triggers the catagen stage of hair follicles, intrafolli-
cular apoptosis, and hair loss [2, 36]. In this study, mast
cells are observed in dermal connective tissues rather
than near hair follicles. Considering a few number of
mast cells in GSE group, GSE treatment contribute anti-
inflammatory action on dermal tissues rather than on
hair follicular epithelium.
Interestingly, this study confirmed that GSE induced
SCF in vivo model by immunohistochemistry. SCF was
strongly expressed in mouse epidermal keratinocytes
and epithelium of hair follicular bulbs. Since the SCF
plays a role in preserving stem cells and participating in
the growth of hair follicles, it is detectable in the anagen
stage [37]. The induction of endothelin-1 and SCF was
correlated with the regeneration of hair follicles [38]. In
concurrence with the previous studies, the strong induc-
tion of SCF in the GSE-treated mice skin suggested that
hDPCs underwent the regeneration process of hair
follicles.
Interestingly, the treatment of 1,000 ppm GSE signifi-
cantly downregulated mRNA expression of VEGF, HGF,
and TGF-β1 in the mouse skin (Fig. 4d). While GSE
upregulated expression of HGF and VEGF on hDPCs,
the expression of HGF and VEGF was downregulated
in mouse skin tissues. Since induction of VEGF and
HGF were required in active anagen phase, they are
expressed in actively growing hair follicles. As 24 h of
GSE treatment induced anagen phase of hDPCs, ex-
pression of VEGF and HGF was upregulated in GSE-
treated hDPCs. However, hair follicles in mouse skin
tissues after 3 weeks of depilation were in catagen
phase rather than anagen when it is considered that
GSE-treated group finished the hair growth faster than
PC or NC. Therefore, catagen phase could explain the
reduced expression of VEGF and HGF in GSE-treated
mouse hair follicles for 3 weeks.
It was surprising finding that TGF-β1 was downregu-
lated in both models. As the function of TGF-β1 is
associated with hair loss, upregulation of TGF-β1 in
hair growth inhibits the growth of hair follicular cells
by accelerating the transition of catagen and telogen.
Thus, downregulation of TGF-β1 could prevent hair
loss in GSE-treated skin by maintaining catagen phase
of hair follicles and viability of follicular cells. Otomo
[39] reported that minoxidil inhibits of TGF-β induced
apoptosis of hair matrix cells by opening the Kir 6.0
channel pore coupled with sulfonylurea receptor on the
mitochondrial inner membrane. The downregulation of
TGF-β1 in both in vitro and in vivo models indicated
that GSE may have the same mechanism with minoxidil
in hair growth activity. Although corilagin and gallic acid
were identified as active components in GSE, there was a
limitation that hair growth effect of each chemical was not
measured. Therefore, their hair growth effect and mech-
anism should be investigated in further study.
Conclusions
This study confirmed that GSE treatment significantly
promoted hair growth, both in vitro and in vivo, by the
proliferation and enhanced migration of hDPCs. GSE
treatment also modulated the expression of HGF, VEGF,
and TGF-β1, which are involved in the growth and in-
hibition of hair follicular cells. The reduced number of
mast cells and the induction of SCF also contributed to
hair regeneration events. Therefore, we concluded that
GSE could enhance hair growth and prevent hair loss.
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